Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 1/1/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Diane Young?

Diane C. Young

Head of Global Medical Affairs

Novartis AG

HQ Phone:  +41 61 696 95 11

Direct Phone: (862) ***-****direct phone

Email: d***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Novartis AG

Lichtstrasse 35

Basel, Basel-City,4056

Switzerland

Company Description

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and bi... more

Find other employees at this company (69,300)

Background Information

Employment History

Supervisor Consumer Response

Gerber Products Company


Contributor

PR Newswire


Vice President, Global Medical Affairs

Novartis Vaccines and Diagnostics Inc


Provider Relations Manager

AseraCare Hospice


Sales Representative

Sepracor Inc.


Affiliations

The Valerie Fund

Board of Trustees Member


Heartland Home Care, Hospice and I.V. Pharmacy

Account Liaison


The Valerie Fund

Board Member


Visiting Angels

Account Liaison-Heartland Home Care, Hospice and I.V.


Visiting Angels

Account Liaison


Education

MD


Web References(107 Total References)


Board of Trustees

www.thevaleriefund.org [cached]

Diane Young, M.D. - GTX
Click here to read biography Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


The Valerie Fund Board of Trustees

www.thevaleriefund.org [cached]

Diane Young, M.D. - GTX
Diane Young, M.D. Diane Young, M.D., Novartis Diane is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she leads a global group of clinical research personnel and oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, and iron chelation therapy. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Board of Trustees - The Valerie Fund

www.thevaleriefund.org [cached]

Diane Young, M.D., Novartis
Diane Young, M.D., Novartis Diane Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Positive results prompt US National Cancer Institute to make Gleevec available to patients in post-surgical GIST study – Gistinfo.org

www.gistinfo.org [cached]

With these new data, we see that Gleevec may help patients with early GIST, said Diane Young, MD, Head of Global Medical Affairs at Novartis Oncology.


The Valerie Fund Elects New Board Members: Diane Young and Joe Mangione

www.thevaleriefund.org [cached]

Diane Young
The new board members are Joe Mangione and Diane Young M.D., oncologist. Dr. Young is currently the Vice President of Clinical Development at Novartis Oncology. In this position, she oversees the development of a diverse pipeline of oncology and hematology products, including targeted therapies, cytotoxic chemotherapy, iron chelation therapy, and others. She leads a global group of clinical research personnel. She has pursued her career in research in the pharmaceutical industry for eighteen years, with positions of increasing responsibility at Hoffman-La Roche, Sandoz, and Johnson and Johnson, prior to joining Novartis.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory